cyclopentane has been researched along with Carcinoma, Squamous Cell in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Guy, RK; Hammill, JT; Kim, HS; Min, J; Rector, J; Schulman, BA; Scott, DC; Singh, B | 1 |
| Boag, G; Chinner, N; Fernandes, K; Garg, AK; Hepburn, LA; Ibrahim, AFM; Leigh, IM; McHugh, A; Proby, CM; Saville, MK | 1 |
| Chen, P; Chu, Y; Dong, Z; Gao, Q; Hoffman, RM; Hu, F; Jeong, LS; Jia, H; Jia, L; Lee, HW; Li, C; Li, H; Li, L; Mei, J; Qi, H; Shi, J; Sun, Y; Wang, M; Wang, P; Wang, Y; Wei, D; Xie, L; Yang, M; Yao, W; Yu, G; Yu, J; Zhu, J | 1 |
| Capone, S; Flescher, E; Iannitti, T; Palmieri, B | 1 |
| Khuri, FR; Lonial, S; Sun, SY; Yue, P; Zhao, L | 1 |
| Bavetsias, V; Gibbs, D; Jackman, AL; Jansen, G; Skelton, LA; Theti, DS; Titley, J | 1 |
| Nikitakis, NG; Sauk, JJ; Siavash, H | 1 |
| Coombs, MM; Croft, CJ | 1 |
| Fujiwara, T; Goto, Y; Ikehara, Y; Kung, HF; Kuwano, M; Nishioka, M; Ono, M; Seguchi, T; Shimada, T | 1 |
9 other study(ies) available for cyclopentane and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.
Topics: Amides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cullin Proteins; Cyclopentanes; Drug Design; Fibroblasts; Glycine; Humans; Intracellular Signaling Peptides and Proteins; NEDD8 Protein; Protein Domains; Protein Interaction Mapping; Pyrazoles; Pyridones; Pyrimidines; Reactive Oxygen Species; Structure-Activity Relationship; Ubiquitin-Conjugating Enzymes | 2019 |
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Cyclopentanes; Drug Screening Assays, Antitumor; Endopeptidases; Endosomal Sorting Complexes Required for Transport; F-Box Proteins; Gene Knockdown Techniques; Humans; Molecular Targeted Therapy; Nuclear Proteins; Pyrimidines; RNA, Small Interfering; Skin Neoplasms; Ubiquitin Thiolesterase; Ubiquitin-Activating Enzymes | 2020 |
Overactivated neddylation pathway as a therapeutic target in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclopentanes; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Lung Neoplasms; Molecular Targeted Therapy; NEDD8 Protein; Pyrimidines; Real-Time Polymerase Chain Reaction; Signal Transduction; Tumor Stem Cell Assay; Ubiquitins | 2014 |
A preliminary study of the local treatment of preneoplastic and malignant skin lesions using methyl jasmonate.
Topics: Acetates; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Compassionate Use Trials; Cyclopentanes; Female; Humans; Lentigo; Leukoplakia; Lichen Planus, Oral; Male; Middle Aged; Neoplasm Recurrence, Local; Oxylipins; Pilot Projects; Precancerous Conditions; Skin Neoplasms; Time Factors; Treatment Outcome | 2011 |
The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Head and Neck Neoplasms; Humans; Proteolysis; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Ubiquitin-Activating Enzymes; Ubiquitination; Up-Regulation | 2011 |
Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.
Topics: Antineoplastic Agents; Biological Transport; Carcinoma, Squamous Cell; Carrier Proteins; Cell Division; Cyclopentanes; Enzyme Inhibitors; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Kinetics; Quinazolines; Receptors, Cell Surface; Recombinant Proteins; Thymidylate Synthase; Transfection; Tumor Cells, Cultured; Vulvar Neoplasms | 2003 |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclopentanes; ErbB Receptors; Humans; Mouth Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
Carcinogenic derivatives of cyclopenta[a]phenanthrene.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Cyclopentanes; Neoplasms, Experimental; Papilloma; Phenanthrenes; Sarcoma, Experimental | 1966 |
Brefeldin A-resistant mutants of human epidermoid carcinoma cell line with structural changes of the Golgi apparatus.
Topics: Brefeldin A; Carcinoma, Squamous Cell; Cyclopentanes; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Humans; Microscopy, Electron; Microscopy, Fluorescence; Monensin; Mutation; Precipitin Tests; Receptors, LDL; Tumor Cells, Cultured | 1992 |